Assessment of the pharmacotherapy influence on mental state deterioration in acute endogenous psychosis

Abstract

Due to the diagnostic difficulties and the lack of clinical recommendations for treatment, assistance in acute endogenous psychoses (atypical, cycloid psychoses) is a hard task in psychiatric practice. The abundance of different therapeutic approaches has not yet been systematically investigated. The data obtained suggest that benzodiazepine monotherapy is the most effective and safe method, while other pharmacological combinations have significant drawbacks and can provoke deterioration of the mental state and the resumption of psychosis. Risk factors for the recurrence of psychosis include the use of antipsychotics in high doses, the combination of several antipsychotics and the addition of cholinolytic drugs to therapy.

Keywords

acute endogenous psychoses / pharmacotherapy / antipsychotics / benzodiazepine

References

[1] Harima H. Diagnosis and treatment of “acute psychosis” from the dimensional perspective. Seishin Shinkeigaku Zasshi. 2011; 113: 1235–1240.

[2] Garcia-Andrade R.F., Diaz-Marsa M., Carrasco J.L. et al. Diagnostic features of the cycloid psychoses in a first psychotic episode sample. J. Affect Disord. 2011; 130: 239–244.

[3] Sakamoto K. Categorical and dimensional diagnostic approach to acute psychosis in view of operational diagnostic criteria. Seishin Shinkeigaku Zasshi. 2011; 113 (12): 1228–1234.

[4] Derito M., Martínez-Rodríguez G., Monchablon-Espinoza A. Las Psicosis Cicloides: Psicosis Bipolares no Maníaco-depresivas. Alcmeón. 2005; 47: 271–299.

[5] García-Andrade R.F., López-Ibor J.J. Acute treatment of cycloid psychosis: study on a sample of naive hospitalized patients with first-episode psychosis (FEP). Actas. Esp. Psiquiatr. 2015; 43 (2): 51–57.

[6] Веракса А.Е., Егоров А.Ю. Сравнение стратегий купирования острых эндогенных психозов. Неврологич. вестн. 2016; XLVIII (1): 36–41. [Veraksa A.E., Egorov A.Yu. Comparison of acute endogenous psychosis management strategies. Nevrologicheskiy vestnik. 2016; XLVIII (1): 36–41. (In Russ.)]

[7] Sienaert P., Dhossche D.M., Vancampfort D. et al. A clinical review of the treatment of catatonia. Front. Psychiatry. 2014; 5: 181. DOI: 10.3389/fpsyt.2014.00181.

[8] Sundararajan Rajagopal. Catatonia. Adv. Psychiatr. Treat. 2007; 13: 51–59.

RIGHTS & PERMISSIONS

Veraksa A.E., Egorov A.Y.